Hemoperfusion: technical aspects and state of the art
Background Blood purification through the removal of plasma solutes by adsorption to beads of charcoal or resins contained in a cartridge (hemoperfusion) has a long and imperfect history. Developments in production and coating technology, however, have recently increased the biocompatibility of sorb...
Saved in:
| Published in: | Critical care (London, England) Vol. 26; no. 1; pp. 135 - 12 |
|---|---|
| Main Authors: | , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
BioMed Central
12.05.2022
Springer Nature B.V BMC |
| Subjects: | |
| ISSN: | 1364-8535, 1466-609X, 1364-8535, 1466-609X, 1366-609X |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background
Blood purification through the removal of plasma solutes by adsorption to beads of charcoal or resins contained in a cartridge (hemoperfusion) has a long and imperfect history. Developments in production and coating technology, however, have recently increased the biocompatibility of sorbents and have spurred renewed interest in hemoperfusion.
Methods
We performed a narrative assessment of the literature with focus on the technology, characteristics, and principles of hemoperfusion. We assessed publications in ex vivo, animal, and human studies. We synthesized such literature in a technical and state-of-the-art summary.
Results
Early hemoperfusion studies were hampered by bioincompatibility. Recent technology, however, has improved its safety. Hemoperfusion has been used with positive effects in chronic dialysis and chronic liver disease. It has also demonstrated extraction of a variety of toxins and drugs during episodes of overdose. Trials with endotoxin binding polymyxin B have shown mixed results in septic shock and are under active investigation. The role of non-selective hemoperfusion in sepsis or inflammation remains. Although new technologies have made sorbents more biocompatible, the research agenda in the field remains vast.
Conclusion
New sorbents markedly differ from those used in the past because of greater biocompatibility and safety. Initial studies of novel sorbent-based hemoperfusion show some promise in specific chronic conditions and some acute states. Systematic studies of novel sorbent-based hemoperfusion are now both necessary and justified. |
|---|---|
| AbstractList | Background Blood purification through the removal of plasma solutes by adsorption to beads of charcoal or resins contained in a cartridge (hemoperfusion) has a long and imperfect history. Developments in production and coating technology, however, have recently increased the biocompatibility of sorbents and have spurred renewed interest in hemoperfusion. Methods We performed a narrative assessment of the literature with focus on the technology, characteristics, and principles of hemoperfusion. We assessed publications in ex vivo, animal, and human studies. We synthesized such literature in a technical and state-of-the-art summary. Results Early hemoperfusion studies were hampered by bioincompatibility. Recent technology, however, has improved its safety. Hemoperfusion has been used with positive effects in chronic dialysis and chronic liver disease. It has also demonstrated extraction of a variety of toxins and drugs during episodes of overdose. Trials with endotoxin binding polymyxin B have shown mixed results in septic shock and are under active investigation. The role of non-selective hemoperfusion in sepsis or inflammation remains. Although new technologies have made sorbents more biocompatible, the research agenda in the field remains vast. Conclusion New sorbents markedly differ from those used in the past because of greater biocompatibility and safety. Initial studies of novel sorbent-based hemoperfusion show some promise in specific chronic conditions and some acute states. Systematic studies of novel sorbent-based hemoperfusion are now both necessary and justified. Background Blood purification through the removal of plasma solutes by adsorption to beads of charcoal or resins contained in a cartridge (hemoperfusion) has a long and imperfect history. Developments in production and coating technology, however, have recently increased the biocompatibility of sorbents and have spurred renewed interest in hemoperfusion. Methods We performed a narrative assessment of the literature with focus on the technology, characteristics, and principles of hemoperfusion. We assessed publications in ex vivo, animal, and human studies. We synthesized such literature in a technical and state-of-the-art summary. Results Early hemoperfusion studies were hampered by bioincompatibility. Recent technology, however, has improved its safety. Hemoperfusion has been used with positive effects in chronic dialysis and chronic liver disease. It has also demonstrated extraction of a variety of toxins and drugs during episodes of overdose. Trials with endotoxin binding polymyxin B have shown mixed results in septic shock and are under active investigation. The role of non-selective hemoperfusion in sepsis or inflammation remains. Although new technologies have made sorbents more biocompatible, the research agenda in the field remains vast. Conclusion New sorbents markedly differ from those used in the past because of greater biocompatibility and safety. Initial studies of novel sorbent-based hemoperfusion show some promise in specific chronic conditions and some acute states. Systematic studies of novel sorbent-based hemoperfusion are now both necessary and justified. Blood purification through the removal of plasma solutes by adsorption to beads of charcoal or resins contained in a cartridge (hemoperfusion) has a long and imperfect history. Developments in production and coating technology, however, have recently increased the biocompatibility of sorbents and have spurred renewed interest in hemoperfusion. We performed a narrative assessment of the literature with focus on the technology, characteristics, and principles of hemoperfusion. We assessed publications in ex vivo, animal, and human studies. We synthesized such literature in a technical and state-of-the-art summary. Early hemoperfusion studies were hampered by bioincompatibility. Recent technology, however, has improved its safety. Hemoperfusion has been used with positive effects in chronic dialysis and chronic liver disease. It has also demonstrated extraction of a variety of toxins and drugs during episodes of overdose. Trials with endotoxin binding polymyxin B have shown mixed results in septic shock and are under active investigation. The role of non-selective hemoperfusion in sepsis or inflammation remains. Although new technologies have made sorbents more biocompatible, the research agenda in the field remains vast. New sorbents markedly differ from those used in the past because of greater biocompatibility and safety. Initial studies of novel sorbent-based hemoperfusion show some promise in specific chronic conditions and some acute states. Systematic studies of novel sorbent-based hemoperfusion are now both necessary and justified. Blood purification through the removal of plasma solutes by adsorption to beads of charcoal or resins contained in a cartridge (hemoperfusion) has a long and imperfect history. Developments in production and coating technology, however, have recently increased the biocompatibility of sorbents and have spurred renewed interest in hemoperfusion.BACKGROUNDBlood purification through the removal of plasma solutes by adsorption to beads of charcoal or resins contained in a cartridge (hemoperfusion) has a long and imperfect history. Developments in production and coating technology, however, have recently increased the biocompatibility of sorbents and have spurred renewed interest in hemoperfusion.We performed a narrative assessment of the literature with focus on the technology, characteristics, and principles of hemoperfusion. We assessed publications in ex vivo, animal, and human studies. We synthesized such literature in a technical and state-of-the-art summary.METHODSWe performed a narrative assessment of the literature with focus on the technology, characteristics, and principles of hemoperfusion. We assessed publications in ex vivo, animal, and human studies. We synthesized such literature in a technical and state-of-the-art summary.Early hemoperfusion studies were hampered by bioincompatibility. Recent technology, however, has improved its safety. Hemoperfusion has been used with positive effects in chronic dialysis and chronic liver disease. It has also demonstrated extraction of a variety of toxins and drugs during episodes of overdose. Trials with endotoxin binding polymyxin B have shown mixed results in septic shock and are under active investigation. The role of non-selective hemoperfusion in sepsis or inflammation remains. Although new technologies have made sorbents more biocompatible, the research agenda in the field remains vast.RESULTSEarly hemoperfusion studies were hampered by bioincompatibility. Recent technology, however, has improved its safety. Hemoperfusion has been used with positive effects in chronic dialysis and chronic liver disease. It has also demonstrated extraction of a variety of toxins and drugs during episodes of overdose. Trials with endotoxin binding polymyxin B have shown mixed results in septic shock and are under active investigation. The role of non-selective hemoperfusion in sepsis or inflammation remains. Although new technologies have made sorbents more biocompatible, the research agenda in the field remains vast.New sorbents markedly differ from those used in the past because of greater biocompatibility and safety. Initial studies of novel sorbent-based hemoperfusion show some promise in specific chronic conditions and some acute states. Systematic studies of novel sorbent-based hemoperfusion are now both necessary and justified.CONCLUSIONNew sorbents markedly differ from those used in the past because of greater biocompatibility and safety. Initial studies of novel sorbent-based hemoperfusion show some promise in specific chronic conditions and some acute states. Systematic studies of novel sorbent-based hemoperfusion are now both necessary and justified. Abstract Background Blood purification through the removal of plasma solutes by adsorption to beads of charcoal or resins contained in a cartridge (hemoperfusion) has a long and imperfect history. Developments in production and coating technology, however, have recently increased the biocompatibility of sorbents and have spurred renewed interest in hemoperfusion. Methods We performed a narrative assessment of the literature with focus on the technology, characteristics, and principles of hemoperfusion. We assessed publications in ex vivo, animal, and human studies. We synthesized such literature in a technical and state-of-the-art summary. Results Early hemoperfusion studies were hampered by bioincompatibility. Recent technology, however, has improved its safety. Hemoperfusion has been used with positive effects in chronic dialysis and chronic liver disease. It has also demonstrated extraction of a variety of toxins and drugs during episodes of overdose. Trials with endotoxin binding polymyxin B have shown mixed results in septic shock and are under active investigation. The role of non-selective hemoperfusion in sepsis or inflammation remains. Although new technologies have made sorbents more biocompatible, the research agenda in the field remains vast. Conclusion New sorbents markedly differ from those used in the past because of greater biocompatibility and safety. Initial studies of novel sorbent-based hemoperfusion show some promise in specific chronic conditions and some acute states. Systematic studies of novel sorbent-based hemoperfusion are now both necessary and justified. |
| ArticleNumber | 135 |
| Author | Bellomo, Rinaldo Ronco, Claudio |
| Author_xml | – sequence: 1 givenname: Claudio surname: Ronco fullname: Ronco, Claudio organization: Department of Medicine, University of Padova, International Renal Research Institute of Vicenza (IRRV), Department of Nephrology, San Bortolo Hospital – sequence: 2 givenname: Rinaldo surname: Bellomo fullname: Bellomo, Rinaldo email: Rinaldo.bellomo@austin.org.au organization: Department of Critical Care, University of Melbourne, Australian and New Zealand Intensive Care Research Centre, Monash University, Data Analytics Research and Evaluation Centre, Austin Hospital, Department of Intensive Care, Austin Hospital, Department of Intensive Care, Royal Melbourne Hospital |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35549999$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9Uk9PFTEcbAxE4OkX8GA28eJlpX93Ww8mhqiQkHjRc9Pt_vpeX_a1z7Yr4dtTWFDgQC9t2pnpZH5zgg5CDIDQO4I_ESK700wYFrzFlLaYY6zaq1fomLCOt1IwcfDofIROct5iTHrZsdfoiAnBVV3HSJzDLu4huTn7GD43BewmeGumxuQ92JIbE8YmF1Ogia4pG2hMKm_QoTNThrf3-wr9_v7t19l5e_nzx8XZ18vWCo5LOzrhnHRYUiMttQOxjBmFHRWE0ZEIOmDhwDrRc-mYFHywQ98R7AYFnDPHVuhi0R2j2ep98juTrnU0Xt9dxLTW1Y23E-ieKArYKDdADaM3cqyJMNdjY2tYo61aXxat_TzsYLQQSjLTE9GnL8Fv9Dr-1QqrXnSsCny8F0jxzwy56J3PFqbJBIhz1rTreK-IqN-u0Idn0G2cU6hR3aI6qqigoqLeP3b0z8rDdCpALgCbYs4JnLa-TqIOqhr0kyZY3xZBL0XQtQj6rgj6qlLpM-qD-osktpByBYc1pP-2X2DdAJ1lxS0 |
| CitedBy_id | crossref_primary_10_4103_jrms_jrms_442_22 crossref_primary_10_1007_s00101_023_01341_w crossref_primary_10_1007_s11560_024_00795_2 crossref_primary_10_1159_000547419 crossref_primary_10_1021_acsomega_4c11595 crossref_primary_10_1038_s41598_024_64379_9 crossref_primary_10_1186_s12876_025_04062_z crossref_primary_10_1002_VIW_20230062 crossref_primary_10_3389_fpubh_2025_1592916 crossref_primary_10_3390_c9030072 crossref_primary_10_3389_fvets_2024_1395967 crossref_primary_10_1021_acs_langmuir_5c02532 crossref_primary_10_1186_s12888_024_05582_w crossref_primary_10_1038_s41581_023_00683_3 crossref_primary_10_3390_jcm13247694 crossref_primary_10_1021_acsbiomaterials_5c01045 crossref_primary_10_3390_jpm14020176 crossref_primary_10_3390_medicina58070844 crossref_primary_10_1007_s10787_024_01494_z crossref_primary_10_3389_fimmu_2023_1074465 crossref_primary_10_3390_ijms242216185 crossref_primary_10_1016_j_tet_2024_134385 crossref_primary_10_1371_journal_pone_0328306 crossref_primary_10_3390_life15071065 crossref_primary_10_1088_1742_6596_2842_1_012005 crossref_primary_10_1111_eci_14229 crossref_primary_10_3389_fbioe_2024_1456694 crossref_primary_10_3390_ani13223532 crossref_primary_10_3390_tropicalmed9090206 crossref_primary_10_1007_s10047_024_01485_5 crossref_primary_10_1007_s10934_025_01843_5 crossref_primary_10_23876_j_krcp_22_223 crossref_primary_10_1016_j_nefroe_2023_12_003 crossref_primary_10_3389_fmed_2025_1491137 crossref_primary_10_3390_jcm13123360 crossref_primary_10_3390_ma16082999 crossref_primary_10_1016_j_cej_2023_142365 crossref_primary_10_1080_00222348_2024_2314413 crossref_primary_10_1134_S2070205124702642 crossref_primary_10_1016_j_clnu_2025_08_031 crossref_primary_10_1016_j_rinma_2025_100699 crossref_primary_10_1007_s00134_022_06810_1 crossref_primary_10_1111_aor_14949 crossref_primary_10_1002_adfm_202415949 crossref_primary_10_1002_adhm_202300999 crossref_primary_10_1039_D5TB01570G crossref_primary_10_1177_03913988231191954 crossref_primary_10_1007_s40121_024_01028_8 crossref_primary_10_5492_wjccm_v13_i4_97631 crossref_primary_10_1159_000533573 crossref_primary_10_1016_j_transci_2023_103853 crossref_primary_10_3389_fneph_2025_1644079 crossref_primary_10_3390_bioengineering12080893 crossref_primary_10_1007_s10517_023_05927_7 crossref_primary_10_2196_55880 crossref_primary_10_24875_RIC_23000221 crossref_primary_10_1186_s40635_025_00740_0 crossref_primary_10_1159_000531951 crossref_primary_10_3390_jpm13071113 crossref_primary_10_24875_RIC_23000223 crossref_primary_10_1016_j_cej_2024_151461 crossref_primary_10_1002_advs_202304287 crossref_primary_10_1111_sdi_13203 crossref_primary_10_3390_medicina61010143 crossref_primary_10_1097_JTCCM_D_23_00016 crossref_primary_10_1016_j_seppur_2024_129837 crossref_primary_10_1002_smtd_202301428 crossref_primary_10_1134_S096554412305002X crossref_primary_10_3390_ijms25147770 crossref_primary_10_1016_j_surfin_2025_107357 crossref_primary_10_1159_000539286 crossref_primary_10_1186_s12944_023_01968_z crossref_primary_10_1007_s11560_022_00620_8 crossref_primary_10_3390_jcm13030763 crossref_primary_10_1159_000547342 crossref_primary_10_1177_03000605241252607 crossref_primary_10_1097_JTCCM_D_25_00015 crossref_primary_10_1016_j_susmat_2024_e00828 crossref_primary_10_1097_IMNA_D_24_00007 crossref_primary_10_1016_j_saa_2025_126411 crossref_primary_10_1159_000542469 crossref_primary_10_1186_s40635_024_00652_5 crossref_primary_10_3390_ma15175989 crossref_primary_10_1097_SHK_0000000000002121 crossref_primary_10_1097_JTCCM_D_25_00011 crossref_primary_10_1159_000547477 crossref_primary_10_1002_smll_202403271 crossref_primary_10_3389_fneur_2024_1342788 crossref_primary_10_3390_jcm14186359 crossref_primary_10_1097_IMNA_D_24_00001 crossref_primary_10_1016_j_ijbiomac_2023_125140 crossref_primary_10_1016_j_seppur_2023_124844 crossref_primary_10_1097_JTCCM_D_24_00011 crossref_primary_10_1097_JTCCM_D_25_00002 crossref_primary_10_12998_wjcc_v12_i22_5151 crossref_primary_10_1093_ckj_sfae406 crossref_primary_10_1039_D5CY00192G crossref_primary_10_3389_fvets_2024_1414426 crossref_primary_10_1016_j_nefro_2025_501360 crossref_primary_10_1097_MAT_0000000000002166 crossref_primary_10_3390_medicina60030434 crossref_primary_10_12998_wjcc_v11_i17_3932 crossref_primary_10_1159_000545988 crossref_primary_10_1016_j_cej_2024_157944 crossref_primary_10_1016_j_seppur_2024_129366 |
| Cites_doi | 10.1371/journal.pone.0246299 10.1159/000505146 10.1186/s40635-018-0177-2 10.1007/s00134-002-1261-2 10.1159/000513161 10.3390/toxins13040246 10.1177/0391398818823762 10.1159/000046952 10.1007/s12072-016-9775-9 10.1159/000490694 10.1097/00002480-200211000-00013 10.5301/ijao.5000591 10.1161/CIRCULATIONAHA.122.061219 10.1159/000170011 10.1159/000102130 10.3390/molecules25153331 10.1159/000520520 10.1093/cid/ciaa224 10.1016/j.jcrc.2020.09.007 10.1159/000067862 10.1097/CCE.0000000000000511 10.1186/s13054-019-2588-1 10.1093/ndt/17.11.1950 10.1097/MD.0000000000019058 10.1159/000490234 10.3389/fped.2021.672260 10.1159/000509107 10.1081/CLT-200050426 10.1053/j.ackd.2021.03.005 10.3390/ijms22168882 10.5152/tjg.2018.17415 10.1111/sdi.12246 10.1177/039139880402700507 10.1007/s00134-015-3751-z 10.1111/j.1744-9987.2010.00825.x 10.1186/s13054-018-2181-z 10.4254/wjh.v13.i8.904 10.1186/s13613-021-00905-6 10.2131/jts.45.611 10.1159/000493523 10.1111/aor.13606 10.1186/cc5780 10.1046/j.1525-1594.2003.07289.x 10.1159/000510983 10.1177/039139880202500105 10.1159/000517430 10.1159/000060242 10.1177/039139889802100604 10.1001/jama.2009.856 10.1001/jama.2018.14618 10.1016/j.ajem.2007.07.032 10.1159/000489921 10.1016/j.toxicon.2021.04.011 10.1159/000511725 10.1046/j.1523-1755.2003.00235.x 10.1097/MD.0000000000006160 10.1111/aor.14024 10.1159/000499076 10.1111/aor.13864 10.21203/rs.3.rs-557453/v1 10.1097/CCM.0000000000005493 10.1159/000468911 10.1016/B978-0-323-44942-7.00189-8 10.1111/j.1744-9987.2012.01083.x 10.1007/s00134-018-5463-7 10.1371/journal.pone.0187015 10.1016/j.ajem.2017.10.048 10.5492/wjccm.v10.i1.22 10.3390/ijms222312786 10.1016/S2213-2600(21)00177-6 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2022 2022. The Author(s). 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2022 – notice: 2022. The Author(s). – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s13054-022-04009-w |
| DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals (DOAJ) |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1364-8535 1466-609X 1366-609X |
| EndPage | 12 |
| ExternalDocumentID | oai_doaj_org_article_7192e0a9fbe0407a8d0093f70ac118dc PMC9097563 35549999 10_1186_s13054_022_04009_w |
| Genre | Journal Article Review |
| GroupedDBID | --- 0R~ 29F 2WC 4.4 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFS ACJQM ADBBV ADUKV AEGXH AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EBD EBLON EBS EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P OK1 PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ ROL RPM RSV SJN SMD SOJ SV3 TR2 U2A UKHRP WOQ YOC .6V AAYXX AFFHD CITATION ALIPV NPM 3V. 7XB 8FK AZQEC COVID DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c540t-df5ff8f082a8c2cb1c33a90f25132d152b05fecf5748f3854bcb7610fb9e443f3 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 131 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000799374600002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1364-8535 1466-609X |
| IngestDate | Mon Nov 10 04:33:54 EST 2025 Tue Nov 04 01:49:07 EST 2025 Sun Nov 09 12:28:26 EST 2025 Tue Oct 14 12:40:48 EDT 2025 Mon Jul 21 05:57:43 EDT 2025 Sat Nov 29 06:02:12 EST 2025 Tue Nov 18 22:29:30 EST 2025 Sat Sep 06 07:25:18 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | 2022. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c540t-df5ff8f082a8c2cb1c33a90f25132d152b05fecf5748f3854bcb7610fb9e443f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://link.springer.com/10.1186/s13054-022-04009-w |
| PMID | 35549999 |
| PQID | 2666292525 |
| PQPubID | 44362 |
| PageCount | 12 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_7192e0a9fbe0407a8d0093f70ac118dc pubmedcentral_primary_oai_pubmedcentral_nih_gov_9097563 proquest_miscellaneous_2664791509 proquest_journals_2666292525 pubmed_primary_35549999 crossref_citationtrail_10_1186_s13054_022_04009_w crossref_primary_10_1186_s13054_022_04009_w springer_journals_10_1186_s13054_022_04009_w |
| PublicationCentury | 2000 |
| PublicationDate | 2022-05-12 |
| PublicationDateYYYYMMDD | 2022-05-12 |
| PublicationDate_xml | – month: 05 year: 2022 text: 2022-05-12 day: 12 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Critical care (London, England) |
| PublicationTitleAbbrev | Crit Care |
| PublicationTitleAlternate | Crit Care |
| PublicationYear | 2022 |
| Publisher | BioMed Central Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: Springer Nature B.V – name: BMC |
| References | DN Cruz (4009_CR52) 2007; 11 4009_CR22 4009_CR66 T Köhler (4009_CR75) 2021; 22 4009_CR23 4009_CR69 S Redant (4009_CR16) 2021; 50 A Lorenzin (4009_CR10) 2019; 48 4009_CR27 G La Manna (4009_CR40) 2018; 46 M Wu (4009_CR41) 2021; 50 A Alharthy (4009_CR60) 2021; 45 A Chris-Olaiya (4009_CR17) 2021; 13 4009_CR62 L Bo (4009_CR47) 2014; 18 X Li (4009_CR31) 2021; 63 D Schädler (4009_CR33) 2017; 12 A Supady (4009_CR63) 2021; 9 S Uchino (4009_CR24) 2002; 48 Q Xiao (4009_CR46) 2020; 45 D Payen (4009_CR54) 2015; 41 WR Clark (4009_CR3) 2017; 190 WP Brouwer (4009_CR61) 2019; 23 4009_CR13 4009_CR14 4009_CR58 V Sazonov (4009_CR34) 2021; 9 JA Kellum (4009_CR38) 2003; 21 4009_CR51 SC Rodeia (4009_CR42) 2021; 2 K Moriyama (4009_CR18) 2021; 22 A Santoro (4009_CR50) 2007; 156 C Ronco (4009_CR1) 2019; 48 G La Greca (4009_CR5) 1998; 21 J Jung (4009_CR43) 2008; 26 JA Roberts (4009_CR29) 2021; 72 I Martin-Loeches (4009_CR30) 2021; 3 T Rampino (4009_CR32) 2021; 50 G Ankawi (4009_CR2) 2018; 22 Z Li (4009_CR39) 2018; 29 DJ Klein (4009_CR56) 2018; 44 DN Cruz (4009_CR53) 2009; 301 AP Sanchez (4009_CR15) 2021; 28 4009_CR45 A Esmaeili Vardanjani (4009_CR64) 2021; 50 C Ronco (4009_CR4) 2002; 137 L Cole (4009_CR20) 2002; 17 X Yang (4009_CR44) 2018; 36 P Morachiello (4009_CR37) 1991; 9 Y Li (4009_CR48) 2021; 197 E Sarti (4009_CR11) 2020; 25 4009_CR7 V Sazonov (4009_CR65) 2021; 9 4009_CR9 AA Nassiri (4009_CR57) 2021; 45 S De Rosa (4009_CR76) 2020; 49 R Paul (4009_CR59) 2021; 10 SW Olson (4009_CR70) 2020; 2 D Pomarè Montin (4009_CR35) 2018; 46 G Ankawi (4009_CR74) 2019; 47 W Kittanamongkolchai (4009_CR49) 2017; 11 Z Huang (4009_CR67) 2013; 17 M Ghannoum (4009_CR12) 2014; 27 C Ronco (4009_CR8) 2001; 19 L Cole (4009_CR21) 2004; 27 D Tomescu (4009_CR77) 2019; 42 WH Li (4009_CR36) 2017; 96 L Cole (4009_CR26) 2002; 17 C Ronco (4009_CR28) 2003; 27 4009_CR71 4009_CR72 4009_CR73 G Klinkmann (4009_CR78) 2020; 44 T Abe (4009_CR6) 2003; 64 RP Dellinger (4009_CR55) 2018; 320 L Chu (4009_CR68) 2020; 99 S Uchino (4009_CR25) 2002; 28 S Uchino (4009_CR19) 2002; 25 |
| References_xml | – ident: 4009_CR58 doi: 10.1371/journal.pone.0246299 – volume: 49 start-page: 502 issue: 4 year: 2020 ident: 4009_CR76 publication-title: Blood Purif doi: 10.1159/000505146 – ident: 4009_CR23 doi: 10.1186/s40635-018-0177-2 – volume: 28 start-page: 651 issue: 5 year: 2002 ident: 4009_CR25 publication-title: Intensive Care Med doi: 10.1007/s00134-002-1261-2 – volume: 50 start-page: 876 issue: 6 year: 2021 ident: 4009_CR41 publication-title: Blood Purif doi: 10.1159/000513161 – ident: 4009_CR51 doi: 10.3390/toxins13040246 – volume: 42 start-page: 190 issue: 4 year: 2019 ident: 4009_CR77 publication-title: Int J Artif Organs doi: 10.1177/0391398818823762 – volume: 19 start-page: 260 year: 2001 ident: 4009_CR8 publication-title: Blood Purif doi: 10.1159/000046952 – volume: 11 start-page: 384 issue: 4 year: 2017 ident: 4009_CR49 publication-title: Hepatol Int doi: 10.1007/s12072-016-9775-9 – volume: 48 start-page: 99 issue: 2 year: 2019 ident: 4009_CR1 publication-title: Blood Purif doi: 10.1159/000490694 – volume: 48 start-page: 650 issue: 6 year: 2002 ident: 4009_CR24 publication-title: ASAIO J doi: 10.1097/00002480-200211000-00013 – ident: 4009_CR22 doi: 10.5301/ijao.5000591 – ident: 4009_CR72 doi: 10.1161/CIRCULATIONAHA.122.061219 – volume: 9 start-page: 148 issue: 3 year: 1991 ident: 4009_CR37 publication-title: Blood Purif doi: 10.1159/000170011 – volume: 156 start-page: 396 year: 2007 ident: 4009_CR50 publication-title: Contrib Nephrol doi: 10.1159/000102130 – volume: 25 start-page: 3331 issue: 15 year: 2020 ident: 4009_CR11 publication-title: Molecules doi: 10.3390/molecules25153331 – ident: 4009_CR45 doi: 10.1159/000520520 – volume: 72 start-page: 1369 issue: 8 year: 2021 ident: 4009_CR29 publication-title: Clin Infect Dis doi: 10.1093/cid/ciaa224 – volume: 63 start-page: 187 year: 2021 ident: 4009_CR31 publication-title: J Crit Care doi: 10.1016/j.jcrc.2020.09.007 – volume: 21 start-page: 6 issue: 1 year: 2003 ident: 4009_CR38 publication-title: Blood Purif doi: 10.1159/000067862 – volume: 3 issue: 9 year: 2021 ident: 4009_CR30 publication-title: Crit Care Explor doi: 10.1097/CCE.0000000000000511 – volume: 23 start-page: 317 issue: 1 year: 2019 ident: 4009_CR61 publication-title: Crit Care doi: 10.1186/s13054-019-2588-1 – ident: 4009_CR7 – volume: 17 start-page: 1950 issue: 11 year: 2002 ident: 4009_CR26 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/17.11.1950 – volume: 99 year: 2020 ident: 4009_CR68 publication-title: Medicine doi: 10.1097/MD.0000000000019058 – volume: 46 start-page: 228 issue: 3 year: 2018 ident: 4009_CR40 publication-title: Blood Purif doi: 10.1159/000490234 – volume: 9 start-page: 67226 year: 2021 ident: 4009_CR34 publication-title: Front Pediatr doi: 10.3389/fped.2021.672260 – volume: 50 start-page: 257 issue: 2 year: 2021 ident: 4009_CR64 publication-title: Blood Purif doi: 10.1159/000509107 – volume: 2 year: 2020 ident: 4009_CR70 publication-title: Crit Care Expl – ident: 4009_CR13 doi: 10.1081/CLT-200050426 – volume: 28 start-page: 59 year: 2021 ident: 4009_CR15 publication-title: Adv Chronic Kidney Dis doi: 10.1053/j.ackd.2021.03.005 – volume: 22 start-page: 8882 year: 2021 ident: 4009_CR18 publication-title: Int J Mol Sci doi: 10.3390/ijms22168882 – volume: 29 start-page: 198 issue: 2 year: 2018 ident: 4009_CR39 publication-title: Turk J Gastroenterol doi: 10.5152/tjg.2018.17415 – volume: 27 start-page: 350 year: 2014 ident: 4009_CR12 publication-title: Seminars Dial doi: 10.1111/sdi.12246 – volume: 27 start-page: 388 issue: 5 year: 2004 ident: 4009_CR21 publication-title: Int J Artif Organs doi: 10.1177/039139880402700507 – volume: 41 start-page: 975 year: 2015 ident: 4009_CR54 publication-title: Intensive Care Med doi: 10.1007/s00134-015-3751-z – ident: 4009_CR66 doi: 10.1111/j.1744-9987.2010.00825.x – volume: 22 start-page: 262 issue: 1 year: 2018 ident: 4009_CR2 publication-title: Crit Care doi: 10.1186/s13054-018-2181-z – volume: 13 start-page: 904 year: 2021 ident: 4009_CR17 publication-title: Worl J Hepatol doi: 10.4254/wjh.v13.i8.904 – ident: 4009_CR27 doi: 10.1186/s13613-021-00905-6 – volume: 45 start-page: 611 issue: 10 year: 2020 ident: 4009_CR46 publication-title: J Toxicol Sci doi: 10.2131/jts.45.611 – volume: 18 start-page: 3521 issue: 22 year: 2014 ident: 4009_CR47 publication-title: Eur Rev Med Pharmacol Sci – volume: 9 year: 2021 ident: 4009_CR65 publication-title: Front Pediatr doi: 10.3389/fped.2021.672260 – volume: 47 start-page: 94 issue: 1–3 year: 2019 ident: 4009_CR74 publication-title: Blood Purif doi: 10.1159/000493523 – volume: 44 start-page: 522 issue: 5 year: 2020 ident: 4009_CR78 publication-title: Artif Organs doi: 10.1111/aor.13606 – volume: 11 start-page: R47 year: 2007 ident: 4009_CR52 publication-title: Crit Care doi: 10.1186/cc5780 – volume: 27 start-page: 792 issue: 9 year: 2003 ident: 4009_CR28 publication-title: Artif Organs doi: 10.1046/j.1525-1594.2003.07289.x – volume: 50 start-page: 290 year: 2021 ident: 4009_CR16 publication-title: Blood Purif doi: 10.1159/000510983 – volume: 25 start-page: 27 issue: 1 year: 2002 ident: 4009_CR19 publication-title: Int J Artif Organs doi: 10.1177/039139880202500105 – ident: 4009_CR69 doi: 10.1159/000517430 – volume: 137 start-page: 158 year: 2002 ident: 4009_CR4 publication-title: Contrib Nephrol doi: 10.1159/000060242 – volume: 21 start-page: 303 year: 1998 ident: 4009_CR5 publication-title: Int J Artif Organs doi: 10.1177/039139889802100604 – volume: 301 start-page: 2445 year: 2009 ident: 4009_CR53 publication-title: JAMA doi: 10.1001/jama.2009.856 – volume: 320 start-page: 1455 issue: 14 year: 2018 ident: 4009_CR55 publication-title: JAMA doi: 10.1001/jama.2018.14618 – volume: 26 start-page: 388.e3 issue: 3 year: 2008 ident: 4009_CR43 publication-title: Am J Emerg Med doi: 10.1016/j.ajem.2007.07.032 – volume: 46 start-page: 187 issue: 3 year: 2018 ident: 4009_CR35 publication-title: Blood Purif doi: 10.1159/000489921 – volume: 197 start-page: 65 year: 2021 ident: 4009_CR48 publication-title: Toxicon doi: 10.1016/j.toxicon.2021.04.011 – volume: 50 start-page: 566 issue: 4–5 year: 2021 ident: 4009_CR32 publication-title: Blood Purif doi: 10.1159/000511725 – volume: 64 start-page: 1522 issue: 4 year: 2003 ident: 4009_CR6 publication-title: Kidney Int doi: 10.1046/j.1523-1755.2003.00235.x – volume: 96 issue: 12 year: 2017 ident: 4009_CR36 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000006160 – volume: 45 start-page: 1338 issue: 11 year: 2021 ident: 4009_CR57 publication-title: Artif Organs doi: 10.1111/aor.14024 – volume: 48 start-page: 18 issue: 1 year: 2019 ident: 4009_CR10 publication-title: Blood Purif doi: 10.1159/000499076 – volume: 45 start-page: E101 issue: 5 year: 2021 ident: 4009_CR60 publication-title: Artif Organs doi: 10.1111/aor.13864 – ident: 4009_CR71 doi: 10.21203/rs.3.rs-557453/v1 – ident: 4009_CR73 doi: 10.1097/CCM.0000000000005493 – volume: 190 start-page: 43 year: 2017 ident: 4009_CR3 publication-title: Contrib Nephrol doi: 10.1159/000468911 – volume: 2 start-page: 1 year: 2021 ident: 4009_CR42 publication-title: Blood Purif – ident: 4009_CR9 doi: 10.1016/B978-0-323-44942-7.00189-8 – volume: 17 start-page: 454 year: 2013 ident: 4009_CR67 publication-title: Ther Apher Dial doi: 10.1111/j.1744-9987.2012.01083.x – volume: 44 start-page: 2205 issue: 12 year: 2018 ident: 4009_CR56 publication-title: Intensive Care Med doi: 10.1007/s00134-018-5463-7 – ident: 4009_CR62 doi: 10.1371/journal.pone.0187015 – ident: 4009_CR14 doi: 10.1159/000510983 – volume: 36 start-page: 926 issue: 6 year: 2018 ident: 4009_CR44 publication-title: Am J Emerg Med doi: 10.1016/j.ajem.2017.10.048 – volume: 10 start-page: 22 issue: 1 year: 2021 ident: 4009_CR59 publication-title: World J Crit Care Med doi: 10.5492/wjccm.v10.i1.22 – volume: 22 start-page: 12786 issue: 23 year: 2021 ident: 4009_CR75 publication-title: Int J Mol Sci doi: 10.3390/ijms222312786 – volume: 12 issue: 10 year: 2017 ident: 4009_CR33 publication-title: PLoS ONE doi: 10.1371/journal.pone.0187015 – volume: 17 start-page: 1950 issue: 11 year: 2002 ident: 4009_CR20 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/17.11.1950 – volume: 9 start-page: 755 issue: 7 year: 2021 ident: 4009_CR63 publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(21)00177-6 |
| SSID | ssj0017863 |
| Score | 2.6568923 |
| SecondaryResourceType | review_article |
| Snippet | Background
Blood purification through the removal of plasma solutes by adsorption to beads of charcoal or resins contained in a cartridge (hemoperfusion) has a... Blood purification through the removal of plasma solutes by adsorption to beads of charcoal or resins contained in a cartridge (hemoperfusion) has a long and... Background Blood purification through the removal of plasma solutes by adsorption to beads of charcoal or resins contained in a cartridge (hemoperfusion) has a... Abstract Background Blood purification through the removal of plasma solutes by adsorption to beads of charcoal or resins contained in a cartridge... |
| SourceID | doaj pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 135 |
| SubjectTerms | Adsorption Biocompatibility Critical care Critical Care Medicine Emergency Medicine Equilibrium Experiments Hemodialysis Immune system Intensive Lifesaving Medicine Medicine & Public Health Membrane separation Plasma Polymers Pore size Review Sorbents Zeolites |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals (DOAJ) dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hCiEuCCiPQItciRuNmo3t2OYGFVUvVD0UqTfLrxGVIFvtg_59xk6ysOV14RpPpNHnmcznzHgG4DW6JGOueeqamGohTUc-18ja8Rg9tsq40JRhE-rsTF9emvOfRn3lmrChPfAA3JEiCpIaZ9AnsjfldMyHcFSNC8SNY8hfX2I902FqzB8o3fHpiozujpb0pZaizpXr2WhNfbMVhkq3_t9RzF8rJW-lS0sUOnkID0b6yN4Naj-CO6l_DPc-jgnyXZCn6ev8Oi1wnf-CvWVDi1baB-bKncolc31k5RYRmyMj9scIgifw6eTDxfFpPU5GqAMxrFUdUSJqpPDtdGiDnwXOnWmQyApvI4Vk30hMAaUSGrmWwgeviCihN0kIjvwp7PTzPj0Hhl45NCTivBNBR0dOapySClEg-ljBbALKhrFteJ5e8cWW44Pu7ACuJXBtAdfeVPBm88710DTjr9LvM_4bydzwujwgM7CjGdh_mUEFe9Pu2dELl5bIR9eaVraygoPNMvlPToq4Ps3XRUYoQ7TYVPBs2OyNJpmLEYGmFbVlBluqbq_0V59Lj27TGCU7XsHhZDA_1PozFC_-BxQv4X5bLF3Ws3YPdlaLddqHu-Hb6mq5eFX85DuQrBWl priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZgi1AvvCmBgoLEDaJmEzu2uSCKWvXCqkIg9Wb5NaUSJMtml_59xo6Tann0wjUeR45nxvNlZjxDyCvQnrmQ89SUzheUyQZ1rmSFrp0zUHGpbRmbTfDFQpydydPkcOtTWuV4JsaD2nU2-MgP0JA0laxYxd4tfxSha1SIrqYWGjfJTqhURmdk5_BocfppiiNwEXupzeuGFmiY2HhtRjQHPZ7ejBYhmz0Isiwut0xTrOD_N9j5Z_bkbyHUaJmO7_7vN90jdxImzd8PQnSf3PDtA3L7Y4q6PyTsxH_vln4Fm-Bae5sPdV-RubmOFzX7XLcuj1eT8g5yhJQ5CuQj8uX46POHkyK1WygswrZ14YABCEBMoIWtrJnbutayBERAdeXQzpuSgbfAOBVQC0aNNRzRFxjpKa2hfkxmbdf6JyQHwzVIJNFGUyucRs2XmjMOQAGMy8h83GllUy3y0BLjm4r_JKJRA3cUckdF7qjLjLye5iyHShzXUh8GBk6UoYp2fNCtzlVSSsUR3vpSSzAep3EtXHDwAC-1xdc6m5H9kW8qqXavrpiWkZfTMCpliLTo1nebSEO5RKwtM7I3SMu0kgDwEJXjCN-So62lbo-0F19j4W9ZSs6aOiNvRom7Wta_t-Lp9V_xjOxWUQlYMa_2yWy92vjn5Jb9ub7oVy-SQv0CRZcm9w priority: 102 providerName: ProQuest |
| Title | Hemoperfusion: technical aspects and state of the art |
| URI | https://link.springer.com/article/10.1186/s13054-022-04009-w https://www.ncbi.nlm.nih.gov/pubmed/35549999 https://www.proquest.com/docview/2666292525 https://www.proquest.com/docview/2664791509 https://pubmed.ncbi.nlm.nih.gov/PMC9097563 https://doaj.org/article/7192e0a9fbe0407a8d0093f70ac118dc |
| Volume | 26 |
| WOSCitedRecordID | wos000799374600002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 1364-8535 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: RBZ dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1364-8535 dateEnd: 20231231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: DOA dateStart: 19980101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1364-8535 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: BENPR dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 1364-8535 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: 7X7 dateStart: 20150101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1364-8535 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: PIMPY dateStart: 20150101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLink Journals customDbUrl: eissn: 1364-8535 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: RSV dateStart: 19970401 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RFiEuvB-BsgoSN4jIJnFsc6OoVTl0tSoPLSfLr4FKkFSbXfr3GXuToIWCBJdIicfRaDyT-eJ5GOAZas9cyHmqc-ezismabC5nmS6dM1hwqW0eD5vgs5lYLOS8Lwrrhmz3ISQZv9TRrEX9sqOvLauykH0eFE9mFzuwR-5OBHM8ffdxjB1wUZdDecyl87ZcUOzUfxm8_D1L8pdQafRARzf_j_dbcKNHnOnrjYrchiu-uQPXTvqY-l1gx_5be-6XuA4bZ6_STVdXWrpUxzLMLtWNS2PhUdpiSoAxJXW7Bx-ODt-_Oc76wxQyS6BslTlkiALJ42thC2umtiy1zJHwTVk48uImZ-gtMl4JLAWrjDWcsBUa6auqxPI-7DZt4x9CioZrlESija6scJrsWmrOOGKFaFwC00G-yvadxsOBF19V_OMQtdrIQ5E8VJSHukjg-TjnfNNn46_UB2HZRsrQIzs-aJefVW9yihN49bmWaDxN41q4sH2DPNeWXutsAvvDoqvecDtFeKUuZMEKlsDTcZhMLsRRdOPbdaSpuCQkLRN4sNGRkZMA3whz0wjf0p4tVrdHmrMvsa23zCVndZnAi0GHfrL1Z1E8-jfyx3C9iGrIsmmxD7ur5do_gav2--qsW05ghy94vIoJ7B0czuank7hLQXfztyfzT5Noaj8Astggjg |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFH4qUwRc2JdAgSDBCaJmEju2kRBiq2bUzmgORSon43iBSpAMszDiT_EbeXaSqYaltx64xosc-3ub3_N7AI-dstT4mKciNTYhVBRIcylNVG5M6TImlE5DsQk2HvOjIzHZgp_dWxgfVtnxxMCoTa39HfkuCpIiExnN6Mvpt8RXjfLe1a6ERgOLfftjhSbb_MXwLZ7vkyzbe3f4ZpC0VQUSjdrJIjGOOscdij7FdabLvs5zJVKHgj7PDIqzMqXOakcZ4S7nlJS6RFs_daWwhOQux3nPwTZBsPMebE-Go8mHtd-C8VC7rZ8XJEFBSLtnOrzYnaO0oCTx0fOecESy2hCFoWLA39TcP6M1f3PZBkm4d-V_28OrcLnVueNXDZFcgy1bXYcLozaq4AbQgf1aT-3MLf3V4fO4yWuL4I1VeIg6j1Vl4vD0Kq5djCpzjAR3E96fyaJvQa-qK3sHYlcy5QR2UaUimhuFnE0oRplzxLnSRNDvTlbqNte6L_nxRQabixeyQYNENMiABrmK4Ol6zLTJNHJq79ceMOuePkt4-FDPPsmW6UiG6rtNlXClxWFMceMvsBxLlcZpjY5gp8OJbFnXXJ6AJIJH62ZkOt6TpCpbL0MfwgTaEiKC2w061yvxCixaHdjCNnC7sdTNlur4c0hsLlLBaJFH8KxD-Mmy_r0Vd0__i4dwcXA4OpAHw_H-PbiUBQKkST_bgd5itrT34bz-vjiezx60xBzDx7PG_i95r4TU |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zb9QwEB5BQRUv3EegQJB4g6jZxI5t3rhWRcCqEof6ZvkaqATJag_69xk7ycJCQUK8xuPIGX8Tf_YcBniIJnAfY56a0oeCcdWQzZW8MLX3FiuhjCvTZRNiNpNHR-rwpyz-FO0-uiT7nIZYpald7c899iYum_0l_Xk5K2IkegShKk7OwjkWLw2K-_V3Hzd-BCGbekyVObXf1nKUqvafRjV_j5j8xW2aVqPppf__jstwcWCi-dMeOlfgTGivwu7bwdd-DfhB-NrNwwLX8UDtSd5Xe6UpzU1Kz1zmpvV5SkjKO8yJSOYEw-vwYfry_fODYrhkoXBE1laFR44okZiAka5yduLq2qgSiffUlafV3ZYcg0MumMRacmadFcS50KrAWI31DdhpuzbcghytMKhIxFjDnPSG7F0ZwQUiQ7Q-g8moa-2GCuTxIowvOu1EZKN7fWjSh0760CcZPNr0mff1N_4q_SxO4UYy1s5OD7rFJz2YohZEakNpFNpA3YSRPh7roCiNo9d6l8HeCAA9GPRSE49pKlXximfwYNNMphj9K6YN3TrJMKGIYasMbvZ42Ywk0jri4tQitpC0NdTtlvb4cyr3rUoleFNn8HjE049h_VkVt_9N_D7sHr6Y6jevZq_vwIUqIZIXk2oPdlaLdbgL59231fFycS_Z13eXTyZG |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hemoperfusion%3A+technical+aspects+and+state+of+the+art&rft.jtitle=Critical+care+%28London%2C+England%29&rft.au=Ronco%2C+Claudio&rft.au=Bellomo%2C+Rinaldo&rft.date=2022-05-12&rft.issn=1364-8535&rft.eissn=1364-8535&rft.volume=26&rft.issue=1&rft_id=info:doi/10.1186%2Fs13054-022-04009-w&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s13054_022_04009_w |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1364-8535&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1364-8535&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1364-8535&client=summon |